SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-267283
Filing Date
2021-09-08
Accepted
2021-09-08 07:46:07
Documents
14
Period of Report
2021-09-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d230238d8k.htm   iXBRL 8-K 30758
2 EX-99.1 d230238dex991.htm EX-99.1 11801
6 GRAPHIC g230238ex.jpg GRAPHIC 2943
  Complete submission text file 0001193125-21-267283.txt   182200

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rptx-20210906.xsd EX-101.SCH 2516
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20210906_lab.xml EX-101.LAB 19418
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20210906_pre.xml EX-101.PRE 12117
7 EXTRACTED XBRL INSTANCE DOCUMENT d230238d8k_htm.xml XML 3742
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 211240719
SIC: 2834 Pharmaceutical Preparations